← FDA Drug Approvals (Drugs@FDA)

CYCLOPHOSPHAMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SAGENT PHARMS INC · Approved 2023-07-17

Drug application

FDA Application #
ANDA214529
Application type
Abbreviated New Drug Application (Generic)
Brand name
CYCLOPHOSPHAMIDE
Generic name
CYCLOPHOSPHAMIDE
Active ingredients
CYCLOPHOSPHAMIDE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
SAGENT PHARMS INC
Manufacturer
Sagent Pharmaceuticals
First approval
2023-07-17

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown